comparemela.com

Latest Breaking News On - சந்தை ஆணையர் தியரி பிரெட்டன் - Page 10 : comparemela.com

EU signs deal with GSK for supply of potential COVID drug

EU Reporter SHARE: The European Union has signed a contract with GlaxoSmithKline (GSK.L) for the supply of up to 220,000 treatments of its investigational monoclonal antibody therapy sotrovimab against COVID-19, it said on Wednesday (28 July), write Francesco Guarascio with additional reporting by Jo Mason, Reuters. The drug, which is developed together with U.S. firm Vir Biotechnology ( VIR.O), can be used for the treatment of high-risk coronavirus patients with mild symptoms who do not require supplemental oxygen, according to the Commission. The deal is a boost to GSK work on potential treatments for COVID-19 after the company played a limited role in the development of vaccines. Rather than making its own coronavirus shot, GSK has focused on supplying its booster to other developers and has partnered with Sanofi (

Coronavirus disinformation: Online platforms take new actions and call for more players to join the Code of Practice

Coronavirus disinformation: Online platforms take new actions and call for more players to join the Code of Practice
eureporter.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eureporter.co Daily Mail and Mail on Sunday newspapers.

EU Cybersecurity: Commission proposes a Joint Cyber Unit to step up response to large-scale security incidents

EU Cybersecurity: Commission proposes a Joint Cyber Unit to step up response to large-scale security incidents Published 1 month ago The Commission is laying out a vision to build a new Joint Cyber Unit to tackle the rising number of serious cyber incidents impacting public services, as well as the life of businesses and citizens across the European Union. Advanced and coordinated responses in the field of cybersecurity have become increasingly necessary, as cyberattacks grow in number, scale and consequences, impacting heavily our security. All relevant actors in the EU need to be prepared to respond collectively and exchange relevant information on a ‘need to share , rather than only ‘need to know , basis.

Big Pharma wants a say as EU revamps industry rules

Already a heavy hitter in Brussels, Big Pharma s clout has only grown during the pandemic. And it has a list of demands. The scramble to secure shots, complete with threats and export bans, has put drugmakers in the limelight like never before and emphasized the strategic importance of the industry. As coronavirus vaccine-makers posted fat profits, CEOs acquired a direct line to the EU and to heads of state. Internal Market Commissioner Thierry Breton boasted in March that he made the rounds calling pharma top executives every morning to check progress on vaccine production. And now, as the European Commission pushes to overhaul EU rules for the industry, drugmakers want to see a return on that political capital.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.